Neumora Therapeutics NMRA
Last Price
52 Week Range
$0.61 - $3.25
Next Earnings Date
Mar 02 2026 (Estimate)
Next Earnings Date
Mar 02 2026 (Est.)
Last Price
NMRA Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Neumora Therapeutics, Inc. | 8-K | November 21, 2025 | |
Neumora Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Neumora Therapeutics, Inc. | 8-K | November 6, 2025 | |
Neumora Therapeutics, Inc. | 8-K | October 27, 2025 | |
Neumora Therapeutics, Inc. | 8-K | October 27, 2025 | |
Neumora Therapeutics, Inc. | 10-Q | August 6, 2025 | |
Neumora Therapeutics, Inc. | 8-K | August 6, 2025 | |
Neumora Therapeutics, Inc. | 8-K | May 30, 2025 | |
Neumora Therapeutics, Inc. | DEFA14A | May 16, 2025 | |
Neumora Therapeutics, Inc. | 8-K | May 16, 2025 | |
Neumora Therapeutics, Inc. | 10-Q | May 12, 2025 | |
Neumora Therapeutics, Inc. | 8-K | May 12, 2025 | |
Neumora Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Neumora Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Neumora Therapeutics, Inc. | PRE 14A | April 11, 2025 | |
Neumora Therapeutics, Inc. | 10-K | March 3, 2025 | |
Neumora Therapeutics, Inc. | 8-K | March 3, 2025 | |
Neumora Therapeutics, Inc. | 8-K | February 13, 2025 | |
Neumora Therapeutics, Inc. | 8-K | January 13, 2025 | |
Neumora Therapeutics, Inc. | 8-K | January 2, 2025 | |
Neumora Therapeutics, Inc. | 10-Q | November 12, 2024 | |
Neumora Therapeutics, Inc. | 8-K | November 12, 2024 | |
Neumora Therapeutics, Inc. | S3ASR | October 1, 2024 | |
Neumora Therapeutics, Inc. | 10-Q | August 6, 2024 | |
Neumora Therapeutics, Inc. | 8-K | August 6, 2024 | |
Neumora Therapeutics, Inc. | 8-K | June 14, 2024 | |
Neumora Therapeutics, Inc. | 10-Q | May 7, 2024 | |
Neumora Therapeutics, Inc. | 8-K | May 7, 2024 | |
Neumora Therapeutics, Inc. | DEFA14A | April 25, 2024 | |
Neumora Therapeutics, Inc. | DEF 14A | April 25, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.